In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome
Creemers, J. H. A.; Roes, K. C. B.; Mehra, N.; Figdor, C. G.; de Vries, I. J. M.; Textor, J.
Show abstract
Late-stage cancer immunotherapy trials often lead to unusual survival curve shapes, like delayed curve separation or a plateauing curve in the treatment arm. It is critical for trial success to anticipate such effects in advance and adjust the design accordingly. Here, we use in silico cancer immunotherapy trials - simulated trials based on three different mathematical models - to assemble virtual patient cohorts undergoing late-stage immunotherapy, chemotherapy, or combination therapies. We find that all three simulation models predict the distinctive survival curve shapes commonly associated with immunotherapies. Considering four aspects of clinical trial design - sample size, endpoint, randomization rate, and interim analyses - we demonstrate how, by simulating various possible scenarios, the robustness of trial design choices can be scrutinized, and possible pitfalls can be identified in advance. We provide readily usable, web-based implementations of our three trial simulation models to facilitate their use by biomedical researchers, doctors, and trialists.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Population Dynamics of Immunological Synapse Formation Induced by Bispecific T-cell Engagers Predict Clinical Pharmacodynamics and Treatment Resistance 94%
- Collaborative hunting in artificial agents with deep reinforcement learning 93%
- Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens 93%
Similar papers in this journal
- Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials 94%
- Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors 94%
- Linear reinforcement learning: Flexible reuse of computation in planning, grid fields, and cognitive control 93%
Similar papers in this journal
Similar papers in this journal
- A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery 96%
- Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysis 92%
- Distinct sets of molecular characteristics define tumor-rejecting neoantigens 92%
Similar papers in this journal
- Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy 94%
- Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade 94%
- Predicting clinical drug response from model systems by non-linear subspace-based transfer learning 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.